title: Clinical and radiographic outcomes of pulpotomized primary molars treated with white or gray mineral trioxide aggregate and ferric sulfate--long-term follow-up.
abstract: OBJECTIVE
  To compare the long-term clinical and radiographic outcomes of pulpotomies in primary molars performed with white or gray Mineral Trioxide Aggregate (MTA) in combination with ferric sulfate (FS), when one package of MTA is used for multiple treatments.
  
  
  METHODS
  Sixty eight children with 86 vital carious primary molars underwent pulpotomy with FS, and grey or white MTA. One package of MTA was used for 7-8 treatments. Clinical and radiographic evaluation was performed before and 6 to 47 months after treatment.
  
  
  RESULTS
  Success rates were similar for pulpotomies performed with white (60-teeth) and grey MTA (16 teeth) (p > 0.05), and for those performed with the addition of FS to white or gray MTA when one package of MTA was used for multiple pulpotomies compared to one package of MTA alone.
  
  
  CONCLUSIONS
  Gray and white MTA in conjunction with FS induce comparable clinical and radiographic success rate. The use of one package of MTA for multiple pulpotomies, combined with FS, is a cost-effective treatment.
authors.affiliation: The Maurice and Gabriela Goldschleger School of Dental Medicine, Tel-Aviv University, Tel-Aviv, Israel.
authors.forename: Gal
authors.initials: G
authors.lastname: Frenkel
authors.forename: Arie
authors.initials: A
authors.lastname: Kaufman
authors.forename: Malka
authors.initials: M
authors.lastname: Ashkenazi
mesh_terms: D017607:Aluminum Compounds / Q000627:therapeutic use*; D017610:Calcium Compounds / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D019140:Dental Care for Children / Q000379:methods; D003731:Dental Caries / Q000601:surgery; D003784:Dental Pulp Calcification / Q000000981:diagnostic imaging; D003791:Dental Pulp Test; D003809:Dentin, Secondary / Q000254:growth & development; D004338:Drug Combinations; D005260:Female; D005290:Ferric Compounds / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006489:Hemostatic Techniques; D006801:Humans; D053208:Kaplan-Meier Estimate; D008297:Male; D008963:Molar / Q000000981:diagnostic imaging / Q000601:surgery*; D010087:Oxides / Q000627:therapeutic use*; D011183:Postoperative Complications; D057872:Pulp Capping and Pulpectomy Agents / Q000627:therapeutic use*; D011672:Pulpotomy / Q000379:methods*; D011859:Radiography; D012387:Root Canal Filling Materials / Q000627:therapeutic use; D017640:Silicates / Q000627:therapeutic use*; D014094:Tooth, Deciduous / Q000000981:diagnostic imaging / Q000601:surgery*; D016896:Treatment Outcome
chemical_list: D017607:Aluminum Compounds; D017610:Calcium Compounds; D004338:Drug Combinations; D005290:Ferric Compounds; D010087:Oxides; D057872:Pulp Capping and Pulpectomy Agents; D012387:Root Canal Filling Materials; D017640:Silicates; C086631:mineral trioxide aggregate; C024823:ferric sulfate